Classifying aging as a disease could speed FDA drug approvals
Article originally published by The Hill. Republished with permission from publisher. Authored by Rimon attorney, Amy Baker. Attorneys Mark H. Mirkin, Steven Colby, JD, Ph.D. and David Devernoe contributed to the piece. The Food and Drug Administration (FDA) considers aging to be a natural process. This makes it difficult to get FDA approval for drugs…